| Bryan Anders, PHARMD | |
|
3300 Providence Dr, Suite 101, Anchorage, AK 99508-4671 | |
| (907) 212-5090 | |
| (907) 212-5091 |
| Full Name | Bryan Anders |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3300 Providence Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336385418 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1798 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bryan Anders, PHARMD 3300 Providence Dr, Suite 101, Anchorage, AK 99508-4671 Ph: (907) 212-5090 | Bryan Anders, PHARMD 3300 Providence Dr, Suite 101, Anchorage, AK 99508-4671 Ph: (907) 212-5090 |
News Archive
Bariatric surgery for obese patients is not cost-saving relative to medical care, shows a 6-year follow-up study in JAMA Surgery.
During the summer of 2019, a global team of experts put their heads together to define the key questions facing the UK government when it comes to biological security.
Fourth-year medical students who participated in an educational intervention were more likely to seek, identify and incorporate into care patient circumstances that may require variation from standard care, compared to students in a control group, according to a study in the September 15 issue of JAMA, a theme issue on medical education.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, particularly in China. However, HCC remains one of the more difficult cancers to treat. It is important to screen for new anti-cancer drugs. A number of dietary compounds possess anti-cancer properties. These dietary compounds may modify the activity of specific targets that control cell proliferation and apoptosis. Galangin could inhibit the methoxyresorufin O-demethylase activity of CYP1A2, CYP1A1 and P-form phenolsulfotransferase.
› Verified 2 days ago
Ciara M Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1650 W Northern Lights Blvd, Pharmacy Dept, Anchorage, AK 99517 Phone: 907-339-0560 | |
Kelly Cutrer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12045 Brandon St, Anchorage, AK 99515 Phone: 907-631-0300 Fax: 907-631-0632 | |
Dr. Kyle Patrick Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 673 Mdg / Sghq, 5955 Zeamer Ave, Anchorage, AK 99506 Phone: 907-580-2778 | |
Dr. Remi Cristen Williamson, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-2117 | |
Evan Michael Ambrose, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1650 W Northern Lights Blvd, Anchorage, AK 99517 Phone: 907-339-0560 | |
Timothy Paul Stone, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 N Muldoon Rd, Anchorage, AK 99504 Phone: 907-332-1004 | |
Jordan E Bell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3260 Providence Dr Ste C520, Anchorage, AK 99508 Phone: 907-212-3420 Fax: 907-212-3429 |